SEMA7A

Last updated

SEMA7A
SEMA7A.png
Available structures
PDB Ortholog search: PDBe RCSB
Identifiers
Aliases SEMA7A , CD108, CDw108, H-SEMA-K1, H-Sema-L, JMH, SEMAK1, SEMAL, semaphorin 7A (John Milton Hagen blood group), PFIC11
External IDs OMIM: 607961; MGI: 1306826; HomoloGene: 2678; GeneCards: SEMA7A; OMA:SEMA7A - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_003612
NM_001146029
NM_001146030

NM_011352

RefSeq (protein)

NP_001139501
NP_001139502
NP_003603

NP_035482

Location (UCSC) Chr 15: 74.41 – 74.43 Mb Chr 9: 57.85 – 57.87 Mb
PubMed search [3] [4]
Wikidata
View/Edit Human View/Edit Mouse

Semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group) (SEMA7A) also known as CD108 (Cluster of Differentiation 108), is a human gene. [5]

Contents

SEMA7A is a membrane-bound semaphorin that associates with cell surfaces via a glycosylphosphatidylinositol (GPI) linkage. SEMA7A is also known as the John-Milton-Hagen (JMH) blood group antigen, an 80-kD glycoprotein expressed on activated lymphocytes and erythrocytes.[supplied by OMIM] [5] SEMA7A is expressed in various adult tissues such as adipose, colon, esophagus, heart, brain, spleen, testis, lung, ovary, and uterus. [6]

Development

SEMA7A promotes axonal growth and is involved in mesoderm derived somite formation. Murine embryonic Sema7A expression is highest on day 7, which is indicative of its role on the differentiation of germ layer structure. [7] Embryonic Sema7A expression is noticeable at all developmental stages as well as in the newborn and adult thymus, indicative of a development T-cell role. [7] In wild type neurons, addition of Sema7A under in vitro conditions promotes elongation and branching in a dose dependent manner. [8] Unlike the majority of semaphorins, SEMA7A enhances axonal growth and is imperative for proper embryonic axonal tract formation. [9] Limited expression of SEMA7A is found in the hindbrain as opposed to an abundance of SEMA7A expression found in both the cranial and trunk neural crest cells, which indicates an involvement in migration and differentiation. [10] Sema7A -/- mice show defects in olfactory tract development. [11]

Tumorigenesis

In normal breast tissue, mRNA expression of SEMA7A is low or not expressed, but activation to re-express SEMA7A occurs in these adult tissues to cause pleiotropic effects which increase tumorigenesis. [12] [13] Tumor cell growth, EMT, lung metastasis and angiogenesis have been linked to increased Sema7a expression in murine models. [14] [15] [16] Increased SEMA7A expression correlates with poor prognosis in breast cancer patients. [13] Tumors increase SEMA7A expression in an involuting environment, but knockout of SEMA7a in mouse models undergoing involution decreases lymphangiogenesis. [17]

Genetics

This protein is known to have eight variants in the extracellular region: seven lie within the Sema domain and one within the PSI domain.[ citation needed ]

Molecular biology

This protein forms dimers.[ citation needed ]

Notes

This protein acts as a receptor for the malaria parasite Plasmodium falciparum .

See also

References

  1. 1 2 3 ENSG00000288455 GRCh38: Ensembl release 89: ENSG00000138623, ENSG00000288455 Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000038264 Ensembl, May 2017
  3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. 1 2 "Entrez Gene: SEMA7A semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group)".
  6. "Tissue expression of SEMA7A - Summary - The Human Protein Atlas". www.proteinatlas.org. Retrieved 2020-04-14.
  7. 1 2 Mine T, Harada K, Matsumoto T, Yamana H, Shirouzu K, Itoh K, et al. (May 2000). "CDw108 expression during T-cell development". Tissue Antigens. 55 (5): 429–436. doi:10.1034/j.1399-0039.2000.550505.x. PMID   10885563.
  8. Moresco EM, Donaldson S, Williamson A, Koleske AJ (June 2005). "Integrin-mediated dendrite branch maintenance requires Abelson (Abl) family kinases". The Journal of Neuroscience. 25 (26): 6105–6118. doi:10.1523/JNEUROSCI.1432-05.2005. PMC   6725048 . PMID   15987940.
  9. Scott GA, McClelland LA, Fricke AF (January 2008). "Semaphorin 7a promotes spreading and dendricity in human melanocytes through beta1-integrins". The Journal of Investigative Dermatology. 128 (1): 151–161. doi: 10.1038/sj.jid.5700974 . PMID   17671519.
  10. Bao ZZ, Jin Z (August 2006). "Sema3D and Sema7A have distinct expression patterns in chick embryonic development". Developmental Dynamics. 235 (8): 2282–2289. doi:10.1002/dvdy.20882. PMC   1564195 . PMID   16804892.
  11. Pasterkamp RJ, Peschon JJ, Spriggs MK, Kolodkin AL (July 2003). "Semaphorin 7A promotes axon outgrowth through integrins and MAPKs". Nature. 424 (6947): 398–405. Bibcode:2003Natur.424..398J. doi:10.1038/nature01790. PMID   12879062. S2CID   12690989.
  12. Moserle L, Casanovas O (March 2012). "Exploiting pleiotropic activities of semaphorins as multi-target therapies for cancer". EMBO Molecular Medicine. 4 (3): 168–170. doi:10.1002/emmm.201200206. PMC   3376851 . PMID   22323445.
  13. 1 2 Black SA, Nelson AC, Gurule NJ, Futscher BW, Lyons TR (September 2016). "Semaphorin 7a exerts pleiotropic effects to promote breast tumor progression". Oncogene. 35 (39): 5170–5178. doi:10.1038/onc.2016.49. PMC   5720143 . PMID   27065336.
  14. Garcia-Areas R, Libreros S, Amat S, Keating P, Carrio R, Robinson P, et al. (2014). "Semaphorin7A promotes tumor growth and exerts a pro-angiogenic effect in macrophages of mammary tumor-bearing mice". Frontiers in Physiology. 5: 17. doi: 10.3389/fphys.2014.00017 . PMC   3914020 . PMID   24550834.
  15. Allegra M, Zaragkoulias A, Vorgia E, Ioannou M, Litos G, Beug H, et al. (October 2012). Chernoff J (ed.). "Semaphorin-7a reverses the ERF-induced inhibition of EMT in Ras-dependent mouse mammary epithelial cells". Molecular Biology of the Cell. 23 (19): 3873–3881. doi:10.1091/mbc.e12-04-0276. PMC   3459863 . PMID   22875994.
  16. Ringnér M, Fredlund E, Häkkinen J, Borg Å, Staaf J (March 2011). Creighton C (ed.). "GOBO: gene expression-based outcome for breast cancer online". PLOS ONE. 6 (3): e17911. Bibcode:2011PLoSO...617911R. doi: 10.1371/journal.pone.0017911 . PMC   3061871 . PMID   21445301.
  17. Elder AM, Tamburini BA, Crump LS, Black SA, Wessells VM, Schedin PJ, et al. (November 2018). "Semaphorin 7A Promotes Macrophage-Mediated Lymphatic Remodeling during Postpartum Mammary Gland Involution and in Breast Cancer". Cancer Research. 78 (22): 6473–6485. doi:10.1158/0008-5472.CAN-18-1642. PMC   6239927 . PMID   30254150.

Further reading

This article incorporates text from the United States National Library of Medicine, which is in the public domain.